Results 171 to 180 of about 3,021 (239)
Exploration of patient blood management metrics for emergency departments: a 4-year retrospective monocenter study. [PDF]
Coisy F +6 more
europepmc +1 more source
Comment on Jeon et al. Predictive Limitations of the Geriatric Trauma Outcome Score: A Retrospective Analysis of Mortality in Elderly Patients with Multiple Traumas and Severe Traumatic Brain Injury. <i>Diagnostics</i> 2025, <i>15</i>, 586. [PDF]
Velasco M +4 more
europepmc +1 more source
Blood transfusion practices in Africa: advances, barriers, and ways of overcoming the barriers - a narrative review. [PDF]
Obeagu EI.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Thirty years of hemovigilance – Achievements and future perspectives
Transfusion Clinique Et Biologique, 2023Since its emergence in the early 1990s, hemovigilance has gradually evolved from a blood safety concept focused on surveillance of adverse reactions and events in patients, to a well-defined system that monitors the entire transfusion chain and improves its safety. The importance of hemovigilance has been recognized globally in a relatively short time,
Tomislav Vuk, Constantina Politis
exaly +4 more sources
Pediatric Hemovigilance and Adverse Transfusion Reactions
Clinics in Laboratory Medicine, 2021Some types of transfusion reactions occur more frequently in the pediatric than the adult population. Allergic reactions are the most common, followed by nonhemolytic transfusion reactions; male children seem most susceptible to such reactions. Platelets are often implicated and pulmonary reactions are understudied in children.
Jeanne E Hendrickson
exaly +3 more sources
Transfusion and Hemovigilance in Pediatrics
Pediatric Clinics of North America, 2013Hemovigilance is an essential part of the transfusion process and is defined as surveillance procedures covering the whole transfusion chain, from collection of blood and its components, intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products and to prevent their ...
P H B Bolton-Maggs
exaly +3 more sources

